Tumor Genetic Analyses of Patients With Metastatic Renal Cell Carcinoma and Extended Benefit From mTOR Inhibitor Therapy
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-13-2345
Full Text
Open PDFAbstract
Available in full text
Date
March 12, 2014
Authors
Publisher
American Association for Cancer Research (AACR)